Advancing Pharmacogenomics for Precision Medicine in Latvia
The status, timeline and source of this project. A free account opens every field.
Source: EU Funding & Tenders Portal
PGx4Latvia aims to strengthen pharmacogenomics (PGx) excellence and research capacity in Latvia, enabling the integration of precision medicine into the healthcare. Despite international progress, PGx application in Latvia remains fragmented, with limited testing availability and clinical uptake. The project addresses this gap through a strategic Twinning collaboration between the Latvian Biomedic
- Status
- Prospective
- Sector
- Hospital, Education
- Location
- Latvia, Netherlands, Estonia
- Updated
- 19 Nov 2026
- Source
- EU Funding & Tenders Portal
ConstructChat
Ask ConstructChat about Advancing Pharmacogenomics for Precision Medicine in Latvia
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | forthcoming |
Taiyo status | Prospective |
Taiyo last update | 2026-11-19 |
Contact
| Not available for this record. |
Description
Description | PGx4Latvia aims to strengthen pharmacogenomics (PGx) excellence and research capacity in Latvia, enabling the integration of precision medicine into the healthcare. Despite international progress, PGx application in Latvia remains fragmented, with limited testing availability and clinical uptake. The project addresses this gap through a strategic Twinning collaboration between the Latvian Biomedical Research and Study Centre, the University of Latvia, Leiden University Medical Center, and the University of Tartu. The project pursues five objectives. First, to elevate research excellence, a PGx clinical pilot will be implemented by analysing Latvian genomic and prescription data, identifying actionable drug-gene pairs, and developing a workflow for PGx-guided prescribing. Second, to establish a scientific network, knowledge transfer will occur via staff exchanges, joint seminars and participation in international PGx consortia, ensuring alignment with global standards. Third, to increase visibility and policy impact, PGx4Latvia will engage stakeholders, update medical curricula, and develop a national PGx implementation strategy. Fourth, to strengthen research management, administrative staff will receive training in project management, ethics, and innovation translation through peer-learning with advanced institutions. Fifth, to foster innovation and brain circulation, the project will deliver training in multi-omics, drug-gene interactions, and organise workshops and an international conference. These objectives will be achieved through integrated work packages combining research, training, mobility, and dissemination, with outputs including publications and collaborations. PGx4Latvia aligns with Horizon Europe Widening by strengthening excellence, partnerships, and research capacity. It contributes to EU priorities by advancing personalised medicine, integrating Latvian genomic data into the European Research Area, and supporting sustainable healthcare innovation. |
Location
Country | Latvia, Netherlands, Estonia |
Source
Source | EU Funding & Tenders Portal |
URL |
More Details
Record type | Project |
Sector | Hospital, Education |
Article published date | 2026-11-15 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
